Skip to main content

Advertisement

ADVERTISEMENT

News

News
12/09/2021
The NEPTUNO study in secondary cardiovascular prevention, involving close to 6,500 patients, also highlights improved control of Cardiovascular Risk Factors and lower demand on healthcare resources than in control cohorts
The NEPTUNO study in secondary cardiovascular prevention, involving close to 6,500 patients, also highlights improved control of Cardiovascular Risk Factors and lower demand on healthcare resources than in control cohorts
The NEPTUNO study in secondary...
12/09/2021
Cath Lab Digest

Advertisement

News
12/08/2021
Stereotaxis announced a publication in Frontiers in Cardiovascular Medicine titled “Atrial Fibrillation Ablation Using Robotic Magnetic Navigation Reduces the Incidence of Silent Cerebral Embolism.”
Stereotaxis announced a publication in Frontiers in Cardiovascular Medicine titled “Atrial Fibrillation Ablation Using Robotic Magnetic Navigation Reduces the Incidence of Silent Cerebral Embolism.”
Stereotaxis announced a...
12/08/2021
EP Lab Digest
News
12/08/2021
Anthos Therapeutics announces that 1287 patients enrolled across 95 global study sites in the AZALEA-TIMI 71 Ph2 study evaluating the safety and tolerability of abelacimab compared to rivaroxaban.
Anthos Therapeutics announces that 1287 patients enrolled across 95 global study sites in the AZALEA-TIMI 71 Ph2 study evaluating the safety and tolerability of abelacimab compared to rivaroxaban.
Anthos Therapeutics announces...
12/08/2021
EP Lab Digest
News
12/06/2021
JACC Focus Seminar aims to address racial and ethnic disparities in health care
JACC Focus Seminar aims to address racial and ethnic disparities in health care
JACC Focus Seminar aims to...
12/06/2021
Cath Lab Digest

Advertisement

News
12/02/2021
Their findings suggest it is the viral vector – in this case, an adenovirus used to shuttle the coronavirus’ genetic material into cells – and the way it binds to platelet factor 4 (PF4) once injected that could be the potential mechanism.
Their findings suggest it is the viral vector – in this case, an adenovirus used to shuttle the coronavirus’ genetic material into cells – and the way it binds to platelet factor 4 (PF4) once injected that could be the potential mechanism.
Their findings suggest it is the...
12/02/2021
Cath Lab Digest
News
12/02/2021
Seasoned electrophysiology sales executive joins the Company to expand the commercial footprint of its signal processing technology for arrhythmia care.
Seasoned electrophysiology sales executive joins the Company to expand the commercial footprint of its signal processing technology for arrhythmia care.
Seasoned electrophysiology sales...
12/02/2021
EP Lab Digest
News
12/02/2021
Trial studying communication between cardiac rhythm management devices aims to expand treatment options for patients who require an ICD.
Trial studying communication between cardiac rhythm management devices aims to expand treatment options for patients who require an ICD.
Trial studying communication...
12/02/2021
EP Lab Digest

Advertisement

News
12/01/2021
Medtronic announced it has completed patient enrollment in its pivotal PULSED AF trial evaluating the PulseSelect™ Pulsed Field Ablation System.
Medtronic announced it has completed patient enrollment in its pivotal PULSED AF trial evaluating the PulseSelect™ Pulsed Field Ablation System.
Medtronic announced it has...
12/01/2021
EP Lab Digest
News
12/01/2021
ContraBand technology helps restore the heart’s functionality and may significantly improve patients’ quality of life.
ContraBand technology helps restore the heart’s functionality and may significantly improve patients’ quality of life.
ContraBand technology helps...
12/01/2021
EP Lab Digest
News
11/30/2021
Inomagen Therapeutics is developing a revolutionary gene therapy to improve the treatment of atrial fibrillation, a condition afflicting 37 million people worldwide.
Inomagen Therapeutics is developing a revolutionary gene therapy to improve the treatment of atrial fibrillation, a condition afflicting 37 million people worldwide.
Inomagen Therapeutics is...
11/30/2021
EP Lab Digest

Advertisement

Advertisement